ELISA screen of novel compounds that inhibit S100P and RAGE binding to identify new candidate drugs as a new therapy for pancreatic cancer.

Deborah Ogbeni; Ramatoulie Camara; David Chau; Stewart Kirton; Pryank Patel; Louise MacKenzie; Sharon Rossiter

ELISA screen of novel compounds that inhibit S100P and RAGE binding to identify new candidate drugs as a new therapy for pancreatic cancer.

Deborah Ogbeni, Ramatoulie Camara, David Chau, Stewart Kirton, Pryank Patel, Louise MacKenzie, Sharon Rossiter

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Article number	256P
Journal	pA2 online
Volume	13
Issue number	3
Publication status	Published - 2015

Access to Document

http://www.pa2online.org/abstracts/vol13issue3abst256p.pdfLicence: Unspecified

Cite this

@article{90dd55aa5ead4dc09f6c37c10aaf7b5b,

title = "ELISA screen of novel compounds that inhibit S100P and RAGE binding to identify new candidate drugs as a new therapy for pancreatic cancer.",

author = "Deborah Ogbeni and Ramatoulie Camara and David Chau and Stewart Kirton and Pryank Patel and Louise MacKenzie and Sharon Rossiter",

year = "2015",

language = "English",

volume = "13",

journal = "pA2 online",

issn = "1741-1157",

publisher = "British Pharmacological Society",

number = "3",

}

TY - JOUR

T1 - ELISA screen of novel compounds that inhibit S100P and RAGE binding to identify new candidate drugs as a new therapy for pancreatic cancer.

AU - Ogbeni, Deborah

AU - Camara, Ramatoulie

AU - Chau, David

AU - Kirton, Stewart

AU - Patel, Pryank

AU - MacKenzie, Louise

AU - Rossiter, Sharon

PY - 2015

Y1 - 2015

M3 - Meeting abstract

VL - 13

JO - pA2 online

JF - pA2 online

SN - 1741-1157

IS - 3

M1 - 256P

ER -